Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12750-12758

  Reeves, Matthew B ^a,b   Compton, Teresa ^a  

^a Novartis Institutes for Biomedical Research   (New Zealand)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RECOMBINANT INTERLEUKIN 6; STAT PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMATURE DENDRITIC CELL; IMMEDIATE EARLY GENE; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LATENCY; VIRUS REACTIVATION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; MYELOID CELLS; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VIRUS ACTIVATION; VIRUS LATENCY;

HUMAN HERPESVIRUS 5;

EID: 81255173599     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05878-11     Document Type: Article

References (45)

1. Bego, M. G., and S. St Jeor. 2006. Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency. Exp. Hematol. 34:555-570.
2. Blankenberg, S., et al. 2001. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 103:2915-2921.
3. Compton, T. 2000. Analysis of cytomegalovirus ligands, receptors, and the entry pathway, p. 53-65. In J. Sinclair (ed.), Methods in molecular medicine: cytomegalovirus protocols. Humana Press, New York, NY.
4. Domm, S., J. Cinatl, and U. Mrowietz. 2008. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br. J. Dermatol. 159:1217-1228.
5. Dumortier, J., et al. 2008. Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J. Virol. 82:6524-6535.
6. Ernst, M., and B. J. Jenkins. 2004. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20:23-32.
7. Fortunato, E. A., A. K. McElroy, I. Sanchez, and D. H. Spector. 2000. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 8:111-119.
8. Gealy, C., et al. 2005. Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. J. Virol. 79:472-485.
9. Goodrum, F., M. Reeves, J. Sinclair, K. High, and T. Shenk. 2007. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945.
10. Grassi, F., et al. 1998. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J. Leukoc. Biol. 64:484-493.
11. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 95:3937-3942.
12. + monocytes. Proc. Natl. Acad. Sci. U. S. A. 107:20039-20044.
13. Heike, T., and T. Nakahata. 2002. Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim. Biophys. Acta 1592:313-321.
14. Heinrich, P. C., et al. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374:1-20.
15. Hertel, L., V. G. Lacaille, H. Strobl, E. D. Mellins, and E. S. Mocarski. 2003. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77: 7563-7574.
16. Hirano, T., T. Matsuda, and K. Nakajima. 1994. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells 12:262-277.
17. Humar, A., et al. 1999. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. J. Infect. Dis. 179:484-488.
18. Isaacson, M. K., L. K. Juckem, and T. Compton. 2008. Virus entry and innate immune activation. Curr. Top. Microbiol. Immunol. 325:85-100.
19. Keller, M. J., et al. 2007. Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway. J. Virol. 81:6669-6681.
20. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883.
21. Legendre, C., and M. Pascual. 2008. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin. Infect. Dis. 46:732-740.
22. Leruez-Ville, M., et al. 2003. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J. Clin. Microbiol. 41:2040-2046.
23. Limaye, A. P., et al. 2008. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300:413-422.
24. Macagno, A., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 28:227-233.
25. Meier, J. L., and M. F. Stinski. 1996. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39:331-342.
26. + bone marrow progenitors. J. Gen. Virol. 77:3099-3102.
27. Mitani, H., et al. 2000. Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. Br. J. Haematol. 109:288-295.
28. Murayama, T., N. Mukaida, K. S. Khabar, and K. Matsushima. 1998. Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. J. Leukoc. Biol. 64:62-67.
29. Prosch, S., R. Wuttke, D. H. Kruger, and H. D. Volk. 2002. NF-kappaB: a potential therapeutic target for inhibition of human cytomegalovirus (re)activation? Biol. Chem. 383:1601-1609.
30. Rahbar, A. R., V. A. Sundqvist, B. Z. Wirgart, L. Grillner, and C. Soderberg-Naucler. 2004. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors. Transfusion 44:1059-1066.
31. Reeves, M. B., P. A. MacAry, P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 102:4140-4145.
32. Reinke, P., S. Prosch, F. Kern, and H. D. Volk. 1999. Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl. Infect. Dis. 1:157-164.
33. Riegler, S., et al. 2000. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81:393-399.
34. Robson, N. C., et al. 2008. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111:2733-2743.
35. Rodems, S. M., and D. H. Spector. 1998. Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J. Virol. 72:9173-9180.
36. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
37. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.
38. Sinclair, J., and P. Sissons. 2006. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87:1763-1779.
39. Sindre, H., et al. 1996. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 88:4526-4533.
40. Sissons, J. G., M. Bain, and M. R. Wills. 2002. Latency and reactivation of human cytomegalovirus. J. Infect. 44:73-77.
41. Slinger, E., et al. 2010. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci. Signal. 3:ra58.
42. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
43. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059-2064.
44. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
45. Yu, J., and K. E. Dolter. 1997. Production of activin A and its roles in inflammation and hematopoiesis. Cytokines Cell Mol. Ther. 3:169-177.